How is industry responding to the covid-19 pandemic?
During the covid-19 pandemic, it is even more important that we connect, share information and help each other meet the unique challenges faced by our industry. The Senior BioPhorum Connect group – consisting of the le...
Interested in being a BioPhorum peer reviewer?
Excellence has always been at the heart of everything we do – from holding face-to-face meetings to publishing technic...
Single-use: Testing, validation and release (TVR) standards
When testing single-use items, at what point is it appropriate to leverage vendor data, and when does an end user need t...
How to make single-use systems supply chain proof?
In the second half of 2020, BioPhorum Drug Substance will publish a comprehensive set of tools and guidance to hel...
Making and moving operational cell banks: Working abstract for an industry white paper.
Moving the site of manufacture for commercial cell banks, microbial or mammalian, the renewal of working cell banks for ...
Avoiding the rabbit holes: how to develop successful ILM-RTRT strategies
Reducing the time-to-release for drug product is a key goal of the industry as it can lower production costs and acceler...
Key updates to Brazilian post-approval change requirements and use of Polysorbate 80 in China
The BioPhorum Post-Approval Strategy Team has been working hard in international regulatory environments over recent yea...
New disinfectant efficacy approach saves member $1.5m through stronger compliance
Cleaning and disinfection are crucial during the drug manufacturing process. However, while these tasks support the cont...
Shared Clean-in-Place Systems: To share or not to share?
The risk of viral contamination is acknowledged when developing biopharmaceutical products derived from mammalian-cell c...
A risk-based approach to second person verification in microbial testing
Ensuring the integrity of microbiological test data is fundamental to drug product quality and patient safety. The FDA...
Standards and best practices to support trace metal quantitation in cell culture chemically defined media and hydrolysates
In March, Dr Bala Ramanathan, Senior Scientist at Janssen presented the latest views, standards and best practices to...
BioPhorum accelerates growth
We are delighted that BioPhorum has been ranked in the fourth annual list of FT 1000 Europe’s Fastest Growing Compani...
To err is human: How to improve risk management through ‘blue-sky’ human performance
In any industry, quality is the building block of everything. People are relied on to deliver the services and products ...
How is industry responding to the covid-19 pandemic?
During the covid-19 pandemic, it is even more important that we connect, share information and help each other meet the ...
Interested in being a BioPhorum peer reviewer?
Excellence has always been at the heart of everything we do – from holding face-to-face meetings to publishing technic...
Single-use: Testing, validation and release (TVR) standards
When testing single-use items, at what point is it appropriate to leverage vendor data, and when does an end user need t...
How to make single-use systems supply chain proof?
In the second half of 2020, BioPhorum Drug Substance will publish a comprehensive set of tools and guidance to hel...
Making and moving operational cell banks: Working abstract for an industry white paper.
Moving the site of manufacture for commercial cell banks, microbial or mammalian, the renewal of working cell banks for ...
Avoiding the rabbit holes: how to develop successful ILM-RTRT strategies
Reducing the time-to-release for drug product is a key goal of the industry as it can lower production costs and acceler...
Key updates to Brazilian post-approval change requirements and use of Polysorbate 80 in China
The BioPhorum Post-Approval Strategy Team has been working hard in international regulatory environments over recent yea...
New disinfectant efficacy approach saves member $1.5m through stronger compliance
Cleaning and disinfection are crucial during the drug manufacturing process. However, while these tasks support the cont...
Shared Clean-in-Place Systems: To share or not to share?
The risk of viral contamination is acknowledged when developing biopharmaceutical products derived from mammalian-cell c...
A risk-based approach to second person verification in microbial testing
Ensuring the integrity of microbiological test data is fundamental to drug product quality and patient safety. The FDA...
Standards and best practices to support trace metal quantitation in cell culture chemically defined media and hydrolysates
In March, Dr Bala Ramanathan, Senior Scientist at Janssen presented the latest views, standards and best practices to...
BioPhorum accelerates growth
We are delighted that BioPhorum has been ranked in the fourth annual list of FT 1000 Europe’s Fastest Growing Compani...
